EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience

CONCLUSION: EGFR mutation status can be assessed using cfDNA for routine purposes and longitudinal assessment of plasma mutation is an easy approach to monitor the therapeutic response or resistance onset.PMID:34003366 | DOI:10.1007/s00432-021-03658-8

Source: Clinical Genitourinary Cancer - May 18, 2021 Category: Cancer & Oncology Authors: Anna Ianza A Di Chicco C Biagi F Giudici A Dicorato A Guglielmi F Variola S Tomasi G Roviello D Generali F Zanconati Source Type: research